Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
Authors
Keywords
-
Journal
HEALTH TECHNOLOGY ASSESSMENT
Volume -, Issue -, Pages 1-92
Publisher
National Institute for Health and Care Research
Online
2023-10-16
DOI
10.3310/nafw3527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Interleukin-6 Receptor Antagonists in Critically Ill Adult Patients with COVID-19 Pneumonia: two Randomised Controlled Trials of the CORIMUNO-19 Collaborative Group
- (2022) Olivier Hermine et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection
- (2022) Meagan P. O’Brien et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2022) Obbina Abani et al. LANCET
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
- (2022) Rachid Rafia et al. VALUE IN HEALTH
- Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
- (2022) E Wesley Ely et al. Lancet Respiratory Medicine
- Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan
- (2022) Mary Rose Angeles et al. BMC PUBLIC HEALTH
- Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study
- (2022) Niklas Broman et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
- (2022) Anil Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
- (2022) Selin Somersan-Karakaya et al. JOURNAL OF INFECTIOUS DISEASES
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
- (2022) Obbina Abani et al. LANCET
- Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
- (2022) Abraham Rutgers et al. PLoS One
- Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial
- (2022) Rongrong Zou et al. Frontiers in Pharmacology
- Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
- (2022) Hugh Montgomery et al. Lancet Respiratory Medicine
- Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
- (2022) Adrian M. Shields et al. Frontiers in Immunology
- Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection
- (2022) Cynthia Portal-Celhay et al. JAMA Network Open
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- (2022) Christopher C Butler et al. LANCET
- Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19
- (2021) Tøri Vigeland Lerum et al. EUROPEAN RESPIRATORY JOURNAL
- Assessment of Thirty‐Day Readmission Rate, Timing, Causes, and Predictors after Hospitalization with COVID‐19
- (2021) Ilhwan Yeo et al. JOURNAL OF INTERNAL MEDICINE
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
- (2021) Joel W. Hay et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
- (2021) Frank G Sandmann et al. LANCET INFECTIOUS DISEASES
- High-dimensional characterization of post-acute sequelae of COVID-19
- (2021) Ziyad Al-Aly et al. NATURE
- Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
- (2021) Daniel Ayoubkhani et al. BMJ-British Medical Journal
- Effect of COVID-19 on Health-Related Quality of Life in Adolescents and Children: A Systematic Review
- (2021) Hadi Nobari et al. International Journal of Environmental Research and Public Health
- Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19
- (2021) M. M. Walle-Hansen et al. BMC Geriatrics
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
- (2021) Florence Ader et al. LANCET INFECTIOUS DISEASES
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
- (2021) Ivan O. Rosas et al. INTENSIVE CARE MEDICINE
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
- (2021) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
- (2021) William A. Fischer et al. Science Translational Medicine
- Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
- (2021) Jozefien Declercq et al. Lancet Respiratory Medicine
- Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
- (2021) Rachael A Evans et al. Lancet Respiratory Medicine
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- (2020) Annemarie B Docherty et al. BMJ-British Medical Journal
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post‐discharge symptoms and rehabilitation needs in survivors of COVID‐19 infection: a cross‐sectional evaluation
- (2020) Stephen J Halpin et al. JOURNAL OF MEDICAL VIROLOGY
- The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic
- (2020) Isabelle Boutron et al. ANNALS OF INTERNAL MEDICINE
- Patient-reported outcome measures after COVID-19: a prospective cohort study
- (2020) Alyson W. Wong et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.
- (2020) S. Rokadiya et al. JOURNAL OF INFECTION
- Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
- (2020) Eve Garrigues et al. JOURNAL OF INFECTION
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients
- (2020) Manuel Taboada et al. BRITISH JOURNAL OF ANAESTHESIA
- Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System
- (2020) John P. Donnelly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
- (2020) Alejandro Piscoya et al. PLoS One
- Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial
- (2017) Desirée Vos-Vromans et al. PLoS One
- Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial
- (2016) E A Stokes et al. BMJ Open
- Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1)2009 Patients
- (2013) Malen Hollmann et al. PLoS One
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
- (2012) Patricia Guyot et al. BMC Medical Research Methodology
- Populating an Economic Model with Health State Utility Values: Moving toward Better Practice
- (2010) Roberta Ara et al. VALUE IN HEALTH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started